Neurometabolic Disorder Market Segment Forecasts up to 2020

up to
The products used in treatment of Pompe Disease are Myozyme/Lumizyme manufactured by Genzyme (subsidiary of Sanofi SA). Fabry disease is a rare form of genetic lysosomal storage disease leading to deficiency in enzyme alpha galactosidase A (a-GAL …
Read more on (blog)

Fabry Disease Therapeutic Pipeline and Development Review H1 2015 Market
Fabry disease is an inherited disorder that results from the buildup of a particular type of fat. The primary defect which allows this to occur is the inherited deficiency of the enzyme, alpha galactosidase A, which is normally responsible for the …
Read more on PR Newswire (press release)

Check Also


Lastest American Trypanosomiasis (Chagas Disease) News

#Chagas #Disease Parasite Prevalent in Texas 'Kissing Bugs&39; The bugs — also known as "assassin ...

Leave a Reply

Your email address will not be published. Required fields are marked *